Sarju Ganatra to Risk Assessment
This is a "connection" page, showing publications Sarju Ganatra has written about Risk Assessment.
Connection Strength
0.681
-
Makwana B, Khadke S, Kumar A, Nasir K, Wadhera R, Shah R, Sheth S, Kong Y, Navas-Acien A, Adamkiewicz G, Rajagopalan S, Al-Kindi S, Dani SS, Moffatt-Bruce S, Ganatra S. Marine Microplastic Levels and the Prevalence of Cardiometabolic Diseases in US Coastline Counties. J Am Heart Assoc. 2025 Jul; 14(13):e039891.
Score: 0.142
-
Sharma S, Barot HV, Schwartzman AD, Ganatra S, Shah SP, Venesy DM, Patten RD. Risk and predictors of dyssynchrony cardiomyopathy in left bundle branch block with preserved left ventricular ejection fraction. Clin Cardiol. 2020 Dec; 43(12):1494-1500.
Score: 0.102
-
Roth AR, Lazris A, Ganatra S. Overuse of Cardiac Testing. Am Fam Physician. 2018 11 15; 98(10):561-563.
Score: 0.090
-
Ganatra S, Sharma A, Levy MS. Re-Evaluating the Safety of Drug-Eluting?Stents in Cancer Patients. JACC Cardiovasc Interv. 2017 11 27; 10(22):2334-2337.
Score: 0.084
-
Vieira de Oliveira Salerno PR, Lewis PGT, Chen Z, Dazard JE, Ganatra S, Ahmed EN, Nasir K, Deo SV, Rajagopalan S, Al-Kindi S. Climate Vulnerability and Cardiovascular-Kidney-Metabolic Disease in the United?States. J Am Heart Assoc. 2025 Jun 03; 14(11):e038251.
Score: 0.035
-
Zordok M, Buda KG, Etiwy M, Dani SS, Ganatra S, Basir B, Alaswad K, Brilakis ES, Megaly M. Comparative analysis of the DanGer Shock trial to randomized cardiogenic shock trials and real-world registries. Cardiovasc Revasc Med. 2025 Nov; 80:57-65.
Score: 0.034
-
Koutroumpakis E, Patel R, Khadke S, Bedrosian A, Kumar A, Kong Y, Connell B, Upadhyay J, Dani SS, Hahn AW, Logothetis CJ, Al-Kindi S, Butler J, Nohria A, Ganatra S, Deswal A. Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy. Cardiovasc Drugs Ther. 2025 Dec; 39(6):1343-1352.
Score: 0.034
-
Nakhla M, Nair A, Balani P, Ujjawal A, Arun Kumar P, Dasari M, Yukselen Z, Bansal K, Ganatra S, Dani SS. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study. Cardiovasc Drugs Ther. 2025 Dec; 39(6):1331-1341.
Score: 0.034
-
Makram OM, Okwuosa T, Addison D, Cortes J, Dent S, Bevel M, Ganatra S, Al-Kindi S, Hedrick CC, Weintraub NL, Wang X, Guha A. Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous Study. J Am Heart Assoc. 2024 Aug 06; 13(15):e035500.
Score: 0.033
-
Ibrahim R, Pham HN, Ganatra S, Javed Z, Nasir K, Al-Kindi S. Social Phenotyping for Cardiovascular Risk Stratification in Electronic Health Registries. Curr Atheroscler Rep. 2024 Sep; 26(9):485-497.
Score: 0.033
-
Khan SU, Dani SS, Ganatra S, Ahmed T, Agalan A, Khadke S, Agarwal S, Zaid S, Arshad HB, Zahid S, Shah AR, Goel SS, Kleiman NS. Percutaneous coronary intervention before transcatheter aortic valve implantation: A propensity score matched analysis. Cardiovasc Revasc Med. 2024 Aug; 65:10-15.
Score: 0.033
-
Zlotoff DA, Hassan MZO, Zafar A, Alvi RM, Awadalla M, Mahmood SS, Zhang L, Chen CL, Ederhy S, Barac A, Banerji D, Jones-O'Connor M, Murphy SP, Armanious M, Forrestal BJ, Kirchberger MC, Coelho-Filho OR, Rizvi MA, Sahni G, Mandawat A, Tocchetti CG, Hartmann S, Gilman HK, Zatarain-Nicol?s E, Mahmoudi M, Gupta D, Sullivan R, Ganatra S, Yang EH, Heinzerling LM, Thuny F, Zubiri L, Reynolds KL, Cohen JV, Lyon AR, Groarke J, Thavendiranathan P, Nohria A, Fradley MG, Neilan TG. Electrocardiographic features of immune checkpoint inhibitor associated myocarditis. J Immunother Cancer. 2021 03; 9(3).
Score: 0.026